Stocks · Health care · Pharmaceutical Preparations

Turn Therapeutics Inc.

TTRX Clue Score40
United States Fiscal year ends December CIK 0002023016 Results filed 12 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Zuraiz Chaudhary
12 Dec 2025
See Remarks
Buy
2,500
$3.50
$8.75K
Arthur F Golden
24 Nov 2025
Director
Buy
9,868
$3.44
$33.95K
Zuraiz Chaudhary
21 Nov 2025
See Remarks
Buy
1,000
$3.29
$3.29K
Arthur F Golden
21 Nov 2025
Director
Buy
20,532
$2.87
$58.93K
Zuraiz Chaudhary
20 Nov 2025
See Remarks
Buy
1,450
$2.61
$3.78K
Zuraiz Chaudhary
17 Nov 2025
See Remarks
Buy
2,500
$3.62
$9.05K

What was left out

Form 4 filings counted 15
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 1,821,882
History held since 10 Oct 2025